GE Healthcare
Patient Side Module,
E-PSM, E-PSMP
For continuous hemodynamic monitoring
Multiparameter hemodynamic module with simultaneous SpO2 features
measurement of 3-, 7- or 12-lead ECG in S/5 modular monitors • Specified accuracy even with moving and restless
and 3-, 7-, 8- or 12-lead ECG in CARESCAPE* modular monitors, patients
both with ST segment analysis, respiration, pulse oximetry, two
temperatures, non-invasive blood pressure and optional two • The scale of plethysmographic waveform can be fixed
invasive blood pressures (in E-PSMP). or set to autoscale according to the user selection
• Variety of SpO2 sensors for various applications
ECG features
Non-invasive blood pressure (NIBP) features
• Continuous 3-, 7-, 8-, and 12-lead ECG with 3, 5, 6, or
10 leadwires and ST segment analysis with CARESCAPE • Direct keys on the module for starting or stopping a
modular monitors single measurement, or initiating or stopping a
NIBP cycle
• Continuous 3-, 7- and 12-lead ECG measurement with
3, 5 or 10 leadwires and ST segment analysis with • Venous stasis for easy cannulation
S/5 modular monitors • Visual indicator for elapsed time from previous
• Manual storage of up to six reference QRS complexes measurement
• Manual or automatic creation of ST snapshots with • Automatic BP hose detection for adult and infant cuffs
CARESCAPE modular monitors‘ ST alarms capability
Respiration rate features
• Compatible with the wide range of Multi-Link* cables and
• Adjustable trigger level with breath indicator
leadwire sets
• Specific slow waveform speed to see different
• Lethal arrhythmia analysis is standard with full
respiratory patterns
arrhythmia recognition as a monitor software option
• Excellent signal quality due to advanced electrical Invasive blood pressure features
interference filtering • Selectable labels for invasive blood pressures
• QT/QTc values are calculated with 5, 6 or 10 leadwires • Waveforms displayed with combined or individual scales
with CARESCAPE modular monitors
• A dedicated wedge pressure (PCWP) measurement
• 12SL* and 12RL* 12-lead ECG analysis available with display view
CARESCAPE modular monitors
• Adjustable cursor to detect changes in the invasive
pressure waveform
Technical Data
Direct function keys Impedance respiration
Auto On/Off Starts/stops NIBP cycle Measurement method Transthoracic impedance
Start/Cancel Starts/stops single NIBP Measuring range Impedance, 0.2 to 32 Ohm
Zero P1 Zeros invasive blood pressure P1 Max base impedance 5 kOhm
Zero P2 Zeros invasive blood pressure P2 Respiration range 4 to 120 breath/min
Accuracy ±5% or ±5 breath/min
Update 10 s
ST segment analysis
Display resolution 1 breath/min
ST segment measured and displayed simultaneously for up to
12 ECG leads Sweep speed (trace) Slow 0.625 mm/s, fast 6.25 mm/s
Alarms Adjustable high and low alarm
ST level range limits for respiration rate, apnea
CARESCAPE modular Note: Impedance respiration measurement is intended for patients over three years old.
monitors -20 to 20 mm WARNING:
CARESCAPE modular monitors: Apnea events -- The monitor may not detect all episodes
S/5 modular monitors -9 to 9 mm of inadequate breathing, nor does it distinguish between central obstructive and mixed
apnea events.
Display resolution 0.1 mm S/5 monitors: These devices are not apnea monitor systems intended to alarm
primarily upon the cessation of breathing. In central apnea it indicates an alarm after a
Averaging Calculated from 8 QRS complexes predetermined time since the last breath detection. Do not attempt to use these devices
for detecting obstructive or mixed apneas, since respiration movements and impedance
ST trends variations may continue in these cases.
CARESCAPE modular
monitors up to 72 hours ECG
S/5 modular monitors up to 72 hours (ICU)
Measurement method
up to 24 hours (ANE)
CARESCAPE modular
QRST complex storage ne complex stored every
O
monitors 3, 7, 8 and 12 lead ECG with 3, 5,
10 minutes and manual storing
6 or 10 leadwires
of 6 complexes
S/5 modular monitors 3, 7 and 12 lead ECG with 3, 5 or
Alarms
10 leadwires
CARESCAPE modular
ECG Lead selection
monitors djustable high and low alarm
A
limits for anterior, inferior, lateral It is possible to monitor simultaneously one or more of the
and individual leads following leads:
S/5 modular monitors djustable high and low alarm
A
CARESCAPE modular
limits for anterior, inferior and
monitors I, II, III, aVL, aVF, aVR, V1, V2, V3,
lateral leads
V4, V5, V6, dV2, dV3, dV4, dV6
S/5 modular monitors I, II, III, aVL, aVF, aVR, V1, V2, V3,
V4, V5, V6
NOTE: All specifications are relevant to S/5 and CARESCAPE modular monitors, unless otherwise noted.
Heart rate Filter modes
Measurement range CARESCAPE modular
monitors 50 Hz power supply frequency:
CARESCAPE modular
Monitoring filter: 0.05 to 32 Hz
monitors 30 to 300 bpm
Diagnostic filter: 0.05 to 150 Hz
S/5 modular monitors 30 to 250 bpm 60 Hz power supply frequency:
Measurement accuracy ±5% or ±5 bpm Monitoring filter: 0.05 to 40 Hz
Diagnostic filter: 0.05 to 150 Hz
Display resolution 1 bpm
Moderate filter: 0.05 to 22 Hz
Display averaging time Maximum filter: 5 to 25 Hz
CARESCAPE module S/5 modular monitors 50 Hz power supply frequency:
monitors 10 s median values Monitoring filter: 0.5 to 30 Hz
ST filter: 0.05 to 30 Hz
S/5 modular monitors Average of 12 s median values,
Diagnostic filter: 0.05 to 150 Hz
or 5 s, depending on monitor
60 Hz power supply frequency:
Display update time Monitoring filter: 0.5 to 40 Hz
CARESCAPE modular ST filter: 0.05 to 40 Hz
monitors 1s Diagnostic filter: 0.05 to 150 Hz
S/5 modular monitors 5 s or 1 s, depending on monitor Defibrillation protection 5000 V, 360 J
Alarms Sweep speed
CARESCAPE modular
CARESCAPE modular monitors 6.25, 12.5, 25 or 50 mm/s
S/5 modular monitors
monitors
S/5 modular monitors 12.5, 25 or 50 mm/s (15“ screen)
Asystole Asystole
Gain
Leads-off detection Leads-off detection,
bradycardia, tachycardia CARESCAPE modular
Adjustable high and low Adjustable high and low alarm monitors 0.5x = 5 mm/mV
alarm limits for heart rate limits for heart rate 1x = 10 mm/mV
2x = 20 mm/mV
V Fib V Fib
4x = 40 mm/mV
V Tach V Tachy
S/5 modular monitors 0.2 to 5.0 cm/mV
Rapid VT 1
Optional: Optional: Pacemaker pulse detection
VT > 2 V Run > 3 CARESCAPE modular
Couplet V Couplet monitors Detection level ±2 mV to ±700 mV
Pulse duration 0.1 to 2 ms
Bigeminy V Bigeminy
Trigeminy V Trigeminy S/5 modular monitors Detection level ±2 mV to ±700 mV
Pulse duration 0.5 to 2 ms
R on T R on T PVC
Missing Beat Missing Beat Allowable offset ±1 Vdc
Multifocal PVCs Multifocal PVCs CMRR
Frequent PVCs Frequent PVCs CARESCAPE modular
Frequent SVC 1 monitors ≥ 90 dB minimum at 50 Hz
Idioventricular rhythm 1 S/5 modular monitors ≥ 95 dB
Long R-R 1
Pacemaker detector may not operate correctly during the use
SV Tachy 1 of high-frequency (HF) surgical equipment. The disturbances
Atrial fibrillation 1 of HF surgical equipment typically cause false positive
pacer detection.
1 Only software version 07 and later.
NOTE: All specifications are relevant to S/5 and CARESCAPE modular monitors, unless otherwise noted.
Invasive blood pressure Temperature
Measurement method Invasive blood pressure is 2 temperature measurement channels
converted to an electrical signal
Measurement method The temperature is measured by
by a pressure transducer. The
a probe whose resistance varies
signal is continuously displayed
when the temperature changes
as a waveform and numeric
value. The invasive pressure Temperature units °C or °F
setup consisting of connecting Numerical display 2 temperatures, differential T2-T1
tubing, pressure transducer,
an intravenous bag of normal Measurement range 10 to 45°C (50 to 113°F)
saline all connected together Measurement accuracy
by stopcocks, is attached to the with sensors ±0.2°C (25 to 45°C) /
catheter. The pressure transducer ±0.4°F (77 to 113°F)
is placed at the same level with
the heart and electrically zeroed ±0.3°C (10 to 24.9°C) /
±0.5°F (50 to 76.9°F)
Measurement range -40 to 320 mmHg
Display resolution ±0.1°C (±0.1°F)
Measurement accuracy ±5% or ± 2 mmHg
Probes Use only GE Healthcare
Waveform display temperature probes or
Range -30 to 300 mmHg defibrillator-proof YSI
400 series probes
Scales Adjustable in 10 mmHg
increments NIBP
Numerical display
Numerical display Systolic, diastolic and mean
Resolution 1 mmHg arterial pressure
Alarms Adjustable high and low alarm Measurement principle Oscillometric with linear deflation
limits for systolic, diastolic and
Measurement range Adult: 25 to 260 mmHg
mean pressures
Child: 25 to 190 mmHg
Pulse rate Infant: 15 to 140 mmHg
CARESCAPE modular Measurement intervals
monitors HR from ART, ABP
CARESCAPE modular
S/5 modular monitors HR from ART monitors 1, 2, 2.5, 3, 4, 5, 10, 15, 20, 30 min,
1 h, 2 h, and 4 h or continous
Measurement range 30 to 250 bpm
STAT mode
Display resolution 1 bpm
S/5 modular monitors 1, 2.5, 3, 5, 10, 15, 30 min, 1 h, 2 h,
Accuracy ±5% or ± 5 bpm 4 h or continuous STAT mode
Transducer sensitivity 5 µV/V/mmHg Alarms Adjustable high and low alarm
Pressure filter 0 to 22 Hz (-3 dB) adjustable limits for systolic, diastolic, mean,
upper limit 4 to 22 Hz cuff loose, cuff occlusion
NOTE: All specifications are relevant to S/5 and CARESCAPE modular monitors, unless otherwise noted.
Typical measurement Plethysmographic pulse waveform
time Adult 23 seconds
Scales 2, 5, 10, 20, 50 mod% or
Infants 20 seconds
automatic scaling
Safety features Adult Child Infant 2 Accuracy is based on deep hypoxia studies with volunteered subjects during non-
motion conditions over a wide range of arterial blood oxygen saturations as com-
Initial inflation pressure pared to arterial blood CO-Oximetry.
(mmHg) 170 150 120 3 About two-thirds of pulse oximeter measurements can be expected to fall within
±Arms of the value measured by a CO-oximeter.
Max. inflation pressure 4 Measurement modules using GE Ohmeda technology with OxyTip+* sensors have
(mmHg) 280 200 145 been validated for pulse rate accuracy over the specified range in bench top testing
against a patient simulator.
Overpressure limit 320 220 160 Note: For each SpO2 accessory, refer to the instructions for use in the accessory
package for patient weight limits.
Max. measurement time 120 120 75
Environment specifications
Note: NIBP measurement is intended for patients weighing over 5 kg/11 lb.
Operating conditions
Pulse oximetry (SpO2) Temperature 10 to 40°C (50 to 104°F)
Relative humidity 10 to 90% non-condensing
Measurement method Red and infrared light absorption
SpO2 Storage conditions
Measurement and
Temperature -25 to 70°C (-13 to 158°F)
display range 0 to 100%
Relative humidity 10 to 90% non-condensing
Calibration range 70 to 100%, calibrated against
functional oxygen saturation
Physical specifications
Measurement
accuracy2 (Arms)3 70 to 100%: ±2 digits (% SpO2) Dimensions (H x W x D) 14.0 x 5.1 x 13.2 (17.1) cm
±3 digits during clinical (5.5 x 2.0 x 5.2 (6.7) in)
patient motion Weight 0.6 kg (1.3 lb)
< 70% unspecified
Display resolution 1 digit (% SpO2) Warranty
Display averaging time One year
CARESCAPE modular
monitors 3 s, 12 s
S/5 modular monitors Adjustable beat-to-beat,
10 s, 20 s
Alarms Adjustable high and low alarm
limits for SpO2 and pulse rate,
probe off, no probe, no pulse
Pulse rate
Measurement and
display range 30 to 250 bpm
Display resolution 1 bpm
Measurement
accuracy 4 ±5% or ±5 bpm, whichever
is greater
NOTE: All specifications are relevant to S/5 and CARESCAPE modular monitors, unless otherwise noted.
© 2012 General Electric Company – All rights reserved.
* GE, GE Monogram, 12RL, 12SL, CARESCAPE and
OxyTip+ are trademarks of General Electric Company.
General Electric Company reserves the right to make
changes in specification and features shown herein, or
discontinue the product described at any time without
notice or obligation. Contact your GE representative for
the most current information
GE Healthcare Finland Oy, a General Electric company,
doing business as GE Healthcare.
GE Healthcare, a division of General Electric Company
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that
are shaping a new age of patient care. Our broad expertise in medical imaging and
information technologies, medical diagnostics, patient monitoring systems, drug
discovery, biopharmaceutical manufacturing technologies, performance improvement
and performance solutions services help our customers to deliver better care to more
people around the world at a lower cost. In addition, we partner with healthcare leaders,
striving to leverage the global policy change necessary to implement a successful shift
to sustainable healthcare systems.
Our “healthymagination” vision for the future invites the world to join us on our
journey as we continuously develop innovations focused on reducing costs, increasing
access and improving quality around the world. Headquartered in the United Kingdom,
GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare
employees are committed to serving healthcare professionals and their patients in more
than 100 countries. For more information about GE Healthcare, visit our website at
www.gehealthcare.com.
GE Healthcare
P.O. Box 900, FIN-00031 GE, Finland
GE Direct United Kingdom: +44 (0)800 0329201
www.gehealthcare.com
EMEA DOC1133430 4/12
(Global version DOC1085720)
